AAM Calls for Time Estimates, Clarifications in Supply Chain Waiver Guidance

Drug Industry Daily
A A
The Association for Accessible Medicines urged the FDA to clarify its draft guidance on Drug Supply Chain Security Act (DSCSA) waivers by adding an estimated timetable for review decisions.

To View This Article:

Login

Subscribe To Drug Industry Daily